2023-07-17 10:46:36 ET
An ophthalmic medical technology and pharmaceutical company, Glaukos ( NYSE: GKOS ) has entered into a collaboration and marketing agreement with Radius XR, whereby Glaukos will become the exclusive sales agent to market, promote, and solicit orders for the Radius XR wearable patient engagement and diagnostic system within the US.
The Radius XR platform is a portable vision diagnostic and patient engagement system designed to enable more efficient detection of eye disease and better management and treatment of sight-threatening conditions.
It enables patients to perform self-guided vision tests with minimal supervision, aiding in eye care practices' flow, efficiency, and patient experience.
More on Glaukos:
-
Glaukos said to have won regional Medicare coverage for glaucoma devices
-
Glaukos upgraded to overweight by Piper Sandler ahead of product launches
For further details see:
Glaukos enters marketing agreement with Radius XR